Dermatology Doctors in Verona, NJ Accepting Medicare

8 Dermatology doctors found. Showing 1 - 8

Robert Nossa, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121    Fax: 973-571-2126

Dr. Michael R. Bilkis, M.D. Dermatology - Procedural Dermatology Medicare: Medicare Enrolled Practice Location: 60 Pomton Avenue, Verona, NJ 07044 Phone: 973-571-2121    Fax: 973-571-2126

Daniel S Groisser, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121    Fax: 973-571-2126

Marcelo Gabriel Horenstein, MD Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121    Fax: 973-571-2126

Stephen Thomas Spates, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121    Fax: 973-571-2126

Justin Brown, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121

Karen Ann Gordon, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-571-2121

Dr. Frederic R Rothman, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 60 Pompton Ave, Verona, NJ 07044 Phone: 973-994-3550    Fax: 973-994-1863

News Archive

Too much ‘tele' raises risk of diabetes, heart disease … and reality TV!

Researchers in a new study say prolonged TV watching is linked to an increased risk of diabetes and heart disease. The study found that every additional two hours spent in front of the TV each day raises the diabetes risk by a fifth and heart disease risk by 15%. The work appears in the journal Journal of the American Medical Association.

FDA-approved cancer drug blunts SARS-CoV-2 protein's detrimental effects

University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2-;the virus that causes COVID-19 – and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects. In their experiments in fruit flies and human cell lines, the team discovered the cell process that the virus hijacks, illuminating new potential candidate drugs that could be tested for treating severe COVID-19 disease patients.

Kaiser Family Foundation report provides first comprehensive look at Defense Department's role in global health

"The Department of Defense is estimated to have spent more than half a billion dollars to support a variety of global health-related activities in fiscal year 2012 - more than either the Centers for Disease Control and Prevention or the National Institutes of Health dedicated to global health in the same year, according to a new report from the Kaiser Family Foundation," a report summary on the foundation's webpage states.

Researchers develop new microsystem for testing drugs to treat epilepsy, MG and cystic fibrosis

Researchers from the University of Southampton, in collaboration with researchers at the University of Quebec at Montreal, have developed a new microsystem for more efficient testing of pharmaceutical drugs to treat diseases such as cystic fibrosis, MG (myasthenia gravis) and epilepsy.

Combination therapy initially, best for blood pressure control: ACCELERATE study

A new study published online Jan. 13 in The Lancet shows that patients with high blood pressure respond better to a combination drug therapy than those on monotherapy. Also patients who undergo the two-drug treatment after taking the single-drug therapy also experience better blood pressure outcomes, though not at the same level as those who began with the combination treatment, according to research.

Read more Medical News

› Verified 3 days ago